E-cigarette use significantly will increase an individual’s risk of developing chronic lung diseases like asthma, bronchitis, emphysema or chronic obstructive pulmonary disease, in accordance with the new UC San Francisco research, the first longitudinal research linking e-cigarettes to respiratory illness in a sample representative of the whole U.S. adult population.
The research also discovered that individuals who used e-cigarettes and in addition, smoked tobacco—by far, the most common pattern amongst adult e-cigarette users—have been at an even higher risk of growing chronic lung disease than those that used either product alone.
The findings had been revealed Dec. 16, 2019, within the American Journal of Preventive Medicine and are based on an evaluation of publicly available information from the Population Assessment of Tobacco and Health (PATH), which tracked e-cigarette and tobacco habits in addition to new lung disease diagnoses in over 32,000 American adults from 2013 to 2016.
Although a number of earlier population research had discovered an association between e-cigarette use and lung disease at a single point in time, these so-known as cross-sectional studies provided a snapshot that made it not possible for researchers to say whether or not lung disease was being caused by e-cigarettes or if people with lung disease had been more probably to make use of e-cigarettes.
By starting with individuals who didn’t have any reported lung disease, taking account of their e-cigarette use and smoking from the beginning, and then following them for 3 years, the new longitudinal study presents stronger evidence of a causal link between adult e-cigarette use and lung diseases than prior research.
This study contributes to the growing case that e-cigarettes have long-term adverse results on health and are making the tobacco epidemic worse.